[19] [20] Reduced caloric intake , while intended for weight loss, can sometimes lead to insufficient energy consumption, particularly if patients are not eating nutrient-dense foods
"Pharmacy Benefit for GLP-1 and/or Anti-Obesity Drug Therapy." bcbsil.com American Medical Association / KFF Analysis
Using GLP-1s for depression, however, has been met with skepticism
Another study (75) showed that danshensu, a potent ROS scavenger, possesses significant pharmacological activities including antioxidant, anti-inflammatory, antiplatelet aggregation, and antitumor effects, and has a wide range of cardiovascular and cerebrovascular protective properties
It is an appealing concept, but one that lacks direct clinical validation through controlled studies